New York, NY -- (SBWIRE) -- 01/13/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Globalstar, Inc (OTCMKTS:GSAT), China Digital TV Holding Co., Ltd (ADR) (NYSE:STV), Verso Paper Corp (NYSE:VRS), Progenics Pharmaceuticals, Inc (NASDAQ:PGNX)
Globalstar, Inc (OTCMKTS:GSAT) showed a volume of 1.27 million shares by the end of last trade whereas the average volume of the stock remained 4.27 million shares. The stock opened the session at $1.78 but then moved to $1.77. At that price, the stock showed a negative performance of -1.12%. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities and transportation. As of March 2, 2012, the Company used 36 in-orbit satellites providing service and 24 active ground stations,
Will GSAT Get Buyers Even After The Recent Rally? Find Out Here
China Digital TV Holding Co., Ltd (ADR) (NYSE:STV) opened the session at $2.12 and closed the session at $2.12. The stock showed a positive performance of 10.99% in previous trading session. Traded with volume of 1.26 million shares in the prior session and the average volume of the stock remained 144,023.00 shares. China Digital TV Holding Co., Ltd. (CDTV Holding) is a provider of conditional access (CA) systems to the People’s Republic of China’s digital television market. The Company’s CA systems, which consist of smart cards, head-end software for television network operators and terminal-end software for set-top box manufacturers, enable digital television network operators in the People’s Republic of China to control the distribution of content and value-added services to their subscribers and block unauthorized access to their networks.
For How Long STV will fight for Profitability? Read This Trend Analysis report
Verso Paper Corp (NYSE:VRS) opened the session at $3.85 and closed the session at $4.15. The stock showed a positive performance of 7.79% in previous trading session. Traded with volume of 1.26 million shares in the prior session and the average volume of the stock remained 855,502.00 shares. The beta of the stock remained 3.29. Verso Paper Corp. (Verso Paper) is a holding company. Verso Paper is engaged in producer of coated freesheet, coated groundwood, and uncoated supercalendered papers. These products are used in catalogs, magazines, retail inserts, and commercial print. The Company operates in three market segments: coated and supercalendered papers; hardwood market pulp, and other, which consists of specialty papers. It is also a supplier of coated papers to catalog and magazine publishers.
Why Should Investors Buy VRS After The Recent Gain? Just Go Here and Find Out
Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) the stock advanced 0.66% and finished the session at $6.10. Traded with volume of 1.26 million shares in the prior session and the average volume of the stock remained 1.01 million shares. The beta of the stock remained 1.24. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways in the growth of aggressive cancers. In gastroenterology, its first commercial product is RELISTOR subcutaneous injection.
Will PGNX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)